TrialInternational journal of radiation oncology, biology, physics2017

Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.

Ryan P Goepfert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.